JP2006500321A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006500321A5 JP2006500321A5 JP2004503504A JP2004503504A JP2006500321A5 JP 2006500321 A5 JP2006500321 A5 JP 2006500321A5 JP 2004503504 A JP2004503504 A JP 2004503504A JP 2004503504 A JP2004503504 A JP 2004503504A JP 2006500321 A5 JP2006500321 A5 JP 2006500321A5
- Authority
- JP
- Japan
- Prior art keywords
- lactalbumin
- variant
- biologically active
- use according
- mutation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0210464.4A GB0210464D0 (en) | 2002-05-08 | 2002-05-08 | Therapeutic treatment |
| PCT/IB2003/002366 WO2003095490A1 (en) | 2002-05-08 | 2003-05-08 | Active complex of alpha-lactalbumin (hamlet) and cofactor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006500321A JP2006500321A (ja) | 2006-01-05 |
| JP2006500321A5 true JP2006500321A5 (enExample) | 2006-06-22 |
Family
ID=9936230
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004503504A Pending JP2006500321A (ja) | 2002-05-08 | 2003-05-08 | α−ラクトアルブミン（ＨＡＭＬＥＴ）および補因子の活性複合体 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US7270822B2 (enExample) |
| EP (1) | EP1506233B8 (enExample) |
| JP (1) | JP2006500321A (enExample) |
| AU (1) | AU2003233116B2 (enExample) |
| CA (1) | CA2485223A1 (enExample) |
| DK (1) | DK1506233T3 (enExample) |
| GB (1) | GB0210464D0 (enExample) |
| WO (1) | WO2003095490A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0210464D0 (en) * | 2002-05-08 | 2002-06-12 | Svanborg Catharina | Therapeutic treatment |
| EP1727561A1 (en) * | 2004-02-26 | 2006-12-06 | HAMLET Pharma AB | Lactalbumin for inhibiting angiogenesis |
| GB0408752D0 (en) * | 2004-04-20 | 2004-05-26 | Hamlet Ltd | Therapeutic treatment |
| EP1715334A1 (fr) * | 2005-04-22 | 2006-10-25 | Adamant Technologies SA | Procédé utilisant un capteur électrochimique et électrodes formant ce capteur |
| GB0518720D0 (en) * | 2005-09-14 | 2005-10-19 | Hamlet Pharma Ab | Therapeutic combination |
| WO2009135494A2 (en) * | 2008-05-09 | 2009-11-12 | Nya Hamlet Pharma Ab | Alpha-lactalbumin composition for the treatment of actinic keratosis |
| WO2010131237A1 (en) * | 2009-05-13 | 2010-11-18 | Agriculture And Food Development Authority (Teagasc) | A process for producing a biologically active globular protein complex |
| US11471497B1 (en) | 2019-03-13 | 2022-10-18 | David Gordon Bermudes | Copper chelation therapeutics |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4348376A (en) | 1980-03-03 | 1982-09-07 | Goldenberg Milton David | Tumor localization and therapy with labeled anti-CEA antibody |
| JP2961625B2 (ja) | 1991-01-21 | 1999-10-12 | 雪印乳業株式会社 | α−ラクトアルブミン含有量の高い組成物の製造方法 |
| US6455673B1 (en) | 1994-06-08 | 2002-09-24 | President And Fellows Of Harvard College | Multi-mutant diphtheria toxin vaccines |
| JP3694319B2 (ja) | 1994-08-16 | 2005-09-14 | サバルワル，ヘマント | 多量体アルファ−ラクトアルブミンを含有する抗菌組成物 |
| US6159748A (en) | 1995-03-13 | 2000-12-12 | Affinitech, Ltd | Evaluation of autoimmune diseases using a multiple parameter latex bead suspension and flow cytometry |
| US5614191A (en) | 1995-03-15 | 1997-03-25 | The United States Of America As Represented By The Department Of Health And Human Services | IL-13 receptor specific chimeric proteins and uses thereof |
| US7053185B1 (en) | 1997-11-21 | 2006-05-30 | Hamlet Pharma Ab | Lactalbumin production process |
| GB9725126D0 (en) | 1997-11-27 | 1998-01-28 | Svanborg Catharina | Therapeutic agents |
| AU3108001A (en) | 2000-01-20 | 2001-12-24 | Coley Pharmaceutical Group, Inc. | Immunostimulatory nucleic acids for inducing a th2 immune response |
| EP1268534A2 (en) | 2000-03-24 | 2003-01-02 | Filgen Biosciences, Inc. | Peptides binding to non-acetylated h3 and h4 histones for cancer therapy |
| CA2405550A1 (en) * | 2000-04-12 | 2001-10-25 | Human Genome Sciences, Inc. | Albumin fusion proteins |
| GB0205347D0 (en) * | 2002-03-07 | 2002-04-24 | Svanborg Catharina | Biologically active complex |
| GB0210464D0 (en) * | 2002-05-08 | 2002-06-12 | Svanborg Catharina | Therapeutic treatment |
| EP1727561A1 (en) * | 2004-02-26 | 2006-12-06 | HAMLET Pharma AB | Lactalbumin for inhibiting angiogenesis |
-
2002
- 2002-05-08 GB GBGB0210464.4A patent/GB0210464D0/en not_active Ceased
-
2003
- 2003-05-08 AU AU2003233116A patent/AU2003233116B2/en not_active Ceased
- 2003-05-08 DK DK03727868.6T patent/DK1506233T3/da active
- 2003-05-08 WO PCT/IB2003/002366 patent/WO2003095490A1/en not_active Ceased
- 2003-05-08 EP EP03727868.6A patent/EP1506233B8/en not_active Expired - Lifetime
- 2003-05-08 US US10/513,740 patent/US7270822B2/en not_active Expired - Lifetime
- 2003-05-08 CA CA002485223A patent/CA2485223A1/en not_active Abandoned
- 2003-05-08 JP JP2004503504A patent/JP2006500321A/ja active Pending
-
2007
- 2007-08-23 US US11/892,499 patent/US7713533B2/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sun et al. | Food protein-derived calcium chelating peptides: A review | |
| US5932259A (en) | Bone reinforcing agent and foods and drinks product containing the same | |
| ES2215940T5 (es) | Traccion proteica basica derivada de la leche como agente para reducir la hipertension. | |
| Austin et al. | Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease | |
| ES2529237T3 (es) | Hidrolizados de proteínas de la leche con potencial inmunogénico reducido | |
| CN1468108A (zh) | 衍生自乳的骨保健组合物 | |
| CY1110497T1 (el) | Χρηση ενωσης που περιεχει ιωδιο για την παραγωγη ιωδιομενων τροφιμων για να αποφευχθουν παθησεις που προκαλουνται απο δυσλειτουργια του θυρεοειδους αδενα | |
| JP2006500321A5 (enExample) | ||
| US7713533B2 (en) | Active complex of α-lactalbumin (HAMLET) and cofactor | |
| JP2005530703A5 (enExample) | ||
| CN100528223C (zh) | 皮肤胶原产生促进剂 | |
| Argyri et al. | Peptides isolated from in vitro digests of milk enhance iron uptake by Caco-2 cells | |
| JP2007524708A5 (enExample) | ||
| CN101842026B (zh) | 骨强化用食品原材料 | |
| GEP20063821B (en) | Orodispersible pharmaceutical composition comprising perindopril | |
| PT2208735E (pt) | Matéria alimentar para promover a diferenciação de osteoblasto e inibir a diferenciação de osteoclasto | |
| ATE344325T1 (de) | Neisseria lactoferrin-bindendes protein | |
| JP2007533728A5 (enExample) | ||
| JP4034516B2 (ja) | 脂質代謝改善剤 | |
| WO2012102100A1 (ja) | 感覚改善剤 | |
| JP2002212096A (ja) | 血圧降下剤 | |
| JP2927076B2 (ja) | 新規タンパク食品素材 | |
| JP2007000094A (ja) | 鉄添加ホエータンパク質濃縮物およびその製造法 | |
| Prasad Patil et al. | Biofunctional properties of milk protein derived bioactive peptides-a review. | |
| Lilla et al. | Bioactive Casein Phosphopeptides in Dairy |